These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 1579299)

  • 21. The efficacy of vaginal clindamycin for the treatment of abnormal genital tract flora in pregnancy.
    Lamont RF; Jones BM; Mandal D; Hay PE; Sheehan M
    Infect Dis Obstet Gynecol; 2003; 11(4):181-9. PubMed ID: 15108863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of intravaginal clindamycin and metronidazole therapy on vaginal lactobacilli in patients with bacterial vaginosis.
    Nyirjesy P; McIntosh MJ; Gattermeir DJ; Schumacher RJ; Steinmetz JI; Joffrion JL
    Am J Obstet Gynecol; 2006 May; 194(5):1277-82. PubMed ID: 16647910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment for Symptomatic Bacterial Vaginosis: ARandomized Controlled Trial.
    Tariq N; Basharat A; Khan DH; Fahim A; Khan MH
    J Coll Physicians Surg Pak; 2017 Nov; 27(11):686-689. PubMed ID: 29132478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy and safety of a single dose of polyhexamethylene biguanide gynaecologic solution versus a seven-dose regimen of vaginal clindamycin cream in patients with bacterial vaginosis.
    Minozzi M; Gerli S; Di Renzo GC; Papaleo E; Ferrari A
    Eur Rev Med Pharmacol Sci; 2008; 12(1):59-65. PubMed ID: 18401974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapeutic regimens for treating bacterial vaginosis in pregnant women].
    Borisov I; Dimitrova V; Mazneĭkova V; Shopova E
    Akush Ginekol (Sofiia); 1999; 38(3):14-6. PubMed ID: 10734670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of intravaginal 0.75% metronidazole gel for the treatment of bacterial vaginosis.
    Hillier SL; Lipinski C; Briselden AM; Eschenbach DA
    Obstet Gynecol; 1993 Jun; 81(6):963-7. PubMed ID: 8497364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of intravaginal clindamycin cream on pregnancy outcome and on abnormal vaginal microbial flora of pregnant women.
    Rosenstein IJ; Morgan DJ; Lamont RF; Sheehan M; Doré CJ; Hay PE; Taylor-Robinson D
    Infect Dis Obstet Gynecol; 2000; 8(3-4):158-65. PubMed ID: 10968599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized trial of the duration of therapy with metronidazole plus or minus azithromycin for treatment of symptomatic bacterial vaginosis.
    Schwebke JR; Desmond RA
    Clin Infect Dis; 2007 Jan; 44(2):213-9. PubMed ID: 17173219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacterial vaginosis in pregnancy and efficacy of short-course oral metronidazole treatment: a randomized controlled trial.
    McDonald HM; O'Loughlin JA; Vigneswaran R; Jolley PT; McDonald PJ
    Obstet Gynecol; 1994 Sep; 84(3):343-8. PubMed ID: 8058228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison of efficacy of combination of ketokonazol 400 mg + clindamycin 100 mg with ketokonazol 800 mg + clindamycin 100 mg in the treatment of vaginitis due to Candida and bacterial vaginosis].
    Godínez V; Garibay M; Mirabent F; Pérez Calderón A
    Ginecol Obstet Mex; 2005 Jun; 73(6):302-7. PubMed ID: 16309036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of bacterial vaginosis with a three day course of 2% clindamycin vaginal cream: a pilot study.
    Dhar J; Arya OP; Timmins DJ; Moss S; Mukembo S; Alawattegama AB; Williams O
    Genitourin Med; 1994 Apr; 70(2):121-3. PubMed ID: 8206470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative study of the therapeutic effects of the Zataria multiflora vaginal cream and metronidazole vaginal gel on bacterial vaginosis.
    Simbar M; Azarbad Z; Mojab F; Majd HA
    Phytomedicine; 2008 Dec; 15(12):1025-31. PubMed ID: 18824338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment with 2% clindamycin vaginal cream prior to first trimester surgical abortion to reduce signs of postoperative infection: a prospective, double-blinded, placebo-controlled, multicenter study.
    Larsson PG; Platz-Christensen JJ; Dalaker K; Eriksson K; Fåhraeus L; Irminger K; Jerve F; Stray-Pedersen B; Wölner-Hanssen P
    Acta Obstet Gynecol Scand; 2000 May; 79(5):390-6. PubMed ID: 10830767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis.
    Sobel JD; Ferris D; Schwebke J; Nyirjesy P; Wiesenfeld HC; Peipert J; Soper D; Ohmit SE; Hillier SL
    Am J Obstet Gynecol; 2006 May; 194(5):1283-9. PubMed ID: 16647911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Efficacy of 5-nitroimidazole derivatives in treatment of bacterial vaginosis].
    Wang FM; Qian XD; Xu H; Yu HY
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(31):2201-3. PubMed ID: 19080672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravaginally applied metronidazole is as effective as orally applied in the treatment of bacterial vaginosis, but exhibits significantly less side effects.
    Brandt M; Abels C; May T; Lohmann K; Schmidts-Winkler I; Hoyme UB
    Eur J Obstet Gynecol Reprod Biol; 2008 Dec; 141(2):158-62. PubMed ID: 18775597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaginal clindamycin and oral metronidazole for bacterial vaginosis: a randomized trial.
    Paavonen J; Mangioni C; Martin MA; Wajszczuk CP
    Obstet Gynecol; 2000 Aug; 96(2):256-60. PubMed ID: 10908773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bacterial vaginosis -- treatment C "Dalacin V" cream].
    Damjanov L
    Akush Ginekol (Sofiia); 2002; 41 Suppl 2():25-6. PubMed ID: 19708191
    [No Abstract]   [Full Text] [Related]  

  • 39. New approaches for the treatment of bacterial vaginosis.
    Sweet RL
    Am J Obstet Gynecol; 1993 Aug; 169(2 Pt 2):479-82. PubMed ID: 8357050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years.
    Mahakit P; Vicente JG; Butt DI; Angeli G; Bansal S; Zambrano D
    Clin Ther; 2006 Jan; 28(1):99-109. PubMed ID: 16490583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.